Ravi Salgia to Endocrine Disruptors
This is a "connection" page, showing publications Ravi Salgia has written about Endocrine Disruptors.
Connection Strength
0.132
-
Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer. Am J Clin Oncol. 2015 Oct; 38(5):442-7.
Score: 0.132
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.